Research from University of Texas Health Science Center Yields New Data on Sickle Cell Anemia (Assessment of End-Organ Damage Among Elderly Patients with Sickle Cell Anemia: A Single-Center Retrospective Study).

A recent study conducted at the University of Texas Health Science Center focused on assessing end-organ damage among elderly patients with sickle cell anemia (SCA). The research found that patients with SCA often experience multiorgan failure, leading to a shorter lifespan compared to the general population. The study included 16 SCA patients aged 60 and older, predominantly female and of African or African American ethnicity, with evidence of end-organ damage affecting multiple systems. The findings suggest that disease-modifying therapies (DMTs) and hereditary persistence of fetal hemoglobin (HPFH) may help manage end-organ outcomes in this cohort. [Extracted from the article]

Copyright of Cardiovascular Week is the property of NewsRx and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)